This site is intended for healthcare professionals only
Prescribing and dispensing organisations must limit prescriptions to licensed indications only and switch some patients from the injection pens to tablets by March, the government has said.
Supply issues for glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are used to manage blood glucose levels in people with type two diabetes, will continue “until at least the end of 2024”, the Department of Health and Social Care (DH) has announced.
Register to gain full access to C+D and C+D Community content
Already registered?
Already registered?
0Margaret Billings sustained fatal injuries when she was caught between a moving boat and a riverbank during a day out “with family and friends”, an inquest has found.
4C+D rounds up some of the immediate pharmacy reaction to news that NHS England will be abolished, with more control moving back to the government and local leaders…
3Wes Streeting has revealed that the DH is “immediately” working to scrap NHS England (NHSE) and put a new “transformation team” in place – adding that it is in the “very final stages” of concluding a new pharmacy contract deal.
1Paydens Pharmacy has announced the rollout of a private prescribing service that allows patients to access same-day care “without needing to see their GP” for £15 per consultation.
5The health secretary has deemed Boots weight loss safeguards “totally unacceptable” after a new Dispatches documentary found that the pharmacy provided a 16-year-old with Wegovy against its own policy.
